Anders Segerstrom - IZafe Group Chief Officer

IZAFE-B Stock

SEK 0.24 0.02 9.09%

Insider

Anders Segerstrom is Chief Officer of iZafe Group AB

Age	38
Phone	46 8 21 11 21
Web	https://www.izafe.se

IZafe Group Management Efficiency

The company has return on total asset (ROA) of (0.2951) % which means that it has lost $0.2951 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5904) %, meaning that it generated substantial loss on money invested by shareholders. IZafe Group's management efficiency ratios could be used to measure how well IZafe Group manages its routine affairs as well as how well it operates its assets and liabilities.

Compare IZafe Group to Peers

Predict price of IZafe Group

iZafe Group AB has accumulated 3.89 M in total debt with debt to equity ratio (D/E) of 95.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. iZafe Group AB has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IZafe Group until it has trouble settling it off, either with new capital or with free cash flow. So, IZafe Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like iZafe Group AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IZafe to invest in growth at high rates of return. When we think about IZafe Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 14 records			INSIDER Age
	Anders MD	Annexin Pharmaceuticals AB	62
	Anna MD	Annexin Pharmaceuticals AB	50
	Tobias Fritz	Acarix AS	44
	Marianne Norskov	Acarix AS	45
	Henrik Palm	Annexin Pharmaceuticals AB	65
	Prof MBA	Sprint Bioscience AB	64
	Helen Round	Acarix AS	59
	Thomas Lundstrm	Acarix AS	49
	Anders Krabbe	Acarix AS	56
	Christian Lindholm	Acarix AS	59
	MSc LLM	Annexin Pharmaceuticals AB	N/A
	Mathias Skalmstad	Sprint Bioscience AB	N/A
	Ulrika Harndahl	Annexin Pharmaceuticals AB	N/A
	Susan Suchdev	Annexin Pharmaceuticals AB	51

iZafe Group AB , a medical technology company, researches, develops, and markets medical products for medication and drug management in Sweden and internationally. The company was formerly known as MediRtt AB and changed its name to iZafe Group AB in May 2019. iZafe Group AB was founded in 2008 and is based in Liding, Sweden. iZafe Group is traded on Stockholm Stock Exchange in Sweden. iZafe Group AB (IZAFE-B) is traded on Stockholm Exchange in Sweden and employs 11 people.

Management Performance

	Return On Equity	-0.59
	Return On Asset	-0.3

iZafe Group AB Leadership Team

Elected by the shareholders, the IZafe Group's board of directors comprises two types of representatives: IZafe Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IZafe. The board's role is to monitor IZafe Group's management team and ensure that shareholders' interests are well served. IZafe Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IZafe Group's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Barbro Sjonell, CoFounder
	Ida Almgren, Chief Officer
	Anders Segerstrom, Chief Officer
	Mikael Svensson, Chief Officer

IZafe Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IZafe Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.59
	Return On Asset	-0.3
	Operating Margin	(27.47) %
	Current Valuation	55.39 M
	Shares Outstanding	153.78 M
	Price To Book	2.42 X
	Price To Sales	66.74 X
	Revenue	442 K
	Gross Profit	246 K
	EBITDA	(28.43 M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Other Information on Investing in IZafe Stock

IZafe Group financial ratios help investors to determine whether IZafe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IZafe with respect to the benefits of owning IZafe Group security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC